Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

TORRENT PHARMACEUTICALS LTD.

NSE : TORNTPHARMBSE : 500420ISIN CODE : INE685A01028Industry : Pharmaceuticals & DrugsHouse : Torrent

BSE2732.6058.8 (+2.2 %)

PREV CLOSE ( ) 2673.80

OPEN PRICE ( ) 2683.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 12576

TODAY'S LOW / HIGH ( )2683.00 2782.00

52 WK LOW / HIGH ( )1599 2782

NSE2734.7064.7 (+2.42 %)

PREV CLOSE( ) 2670.00

OPEN PRICE ( ) 2672.30

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 2734.70 (7)

VOLUME 939897

TODAY'S LOW / HIGH( ) 2672.30 2782.85

52 WK LOW / HIGH ( )1598.45 2782.85

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 15-07 1972

Management Info

Samir Mehta - Chairman - Managing Director

Registered Office

Address Torrent House,Off Ashram Road,,
Ahmedabad,
Gujarat-380009

Phone 079-26599000

Email investorservices@torrentpharma.com

Website www.torrentpharma.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE, MCX

NEWS

06Mar USFDA issues EIR to Torrent Pharmaceut
The United States Food and Drug Administration (USFDA) has successfully..

05Feb Torrent Pharmaceuticals hits 52-week h
Torrent Pharmaceuticals is currently trading at Rs. 2679.90, up by 155.2..

03Feb Torrent Pharmaceuticals reports 52% ri
Torrent Pharmaceuticals has reported results for third quarter ended Dec..

02Feb Torrent Pharmaceuticals informs about
Torrent Pharmaceuticals has informed that the Presentation on unaudited..

12Jan Torrent Pharmaceuticals informs about
Torrent Pharmaceuticals has informed that a meeting of the Board of Dire..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	2970	10520
Gross Profit	4300	15770
Operating Profit	6900	25470
Net Sales	21230	76950

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Ajanta Pharma (BSE) 2377.00 (6.44%)	M.Cap ( in Cr)29930.39
Alkem Laboratories (BSE) 4899.45 (2.36%)	M.Cap ( in Cr)58580.27
Astrazeneca Pharma I (BSE) 5424.45 (1.70%)	M.Cap ( in Cr)13561.13
Dr. Reddy's Lab (BSE) 6349.95 (0.98%)	M.Cap ( in Cr)105928.76
Jenburkt Pharma (BSE) 840.85 (4.94%)	M.Cap ( in Cr)371.09

Shareholding Pattern

	PROMOTERS	71.25%
	NON-INSTITUTION	7.36%
	MUTUAL FUNDS/UTI	4.46%
	FI/BANKS/INSURANCE	1.95%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Aditya Birla SL Pha...	7.24
LIC MF Healthcare F...	5.23
HDFC Pharma and Hea...	4.19
Mirae Asset Healthc...	3.83
ICICI Pru Nifty Pha...	3.64
Nippon India Nifty ...	3.64
PGIM India Arbitrag...	3.39

Risk Disclosures on Derivatives

Smart Quotes

TORRENT PHARMACEUTICALS LTD.